MedPath

JOHNSON & JOHNSON PHARMACEUTICAL RESEARCH & DEVELOPMET L.L.C.

πŸ‡ΊπŸ‡ΈUnited States
Ownership
-
Employees
-
Market Cap
-
Website

A Study of Steady-state Carbamazepine on the Single-dose of Erdafitinib Tablets in Healthy Adult Participants

Phase 1
Completed
Conditions
Healthy
Interventions
First Posted Date
2020-04-01
Last Posted Date
2023-06-29
Lead Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Target Recruit Count
15
Registration Number
NCT04330248
Locations
πŸ‡§πŸ‡ͺ

Clinical Pharmacology Unit, Merksem, Belgium

A Study of Effect of Food on the Pharmacokinetics of a Single JNJ-39823277 (TPI-1062) Dose in Healthy Participants

Phase 1
Completed
Conditions
Healthy
Interventions
First Posted Date
2014-04-04
Last Posted Date
2014-06-25
Lead Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Target Recruit Count
32
Registration Number
NCT02103985

A Study to Evaluate of the Absorption, Metabolism, and Excretion of 14C-JNJ-39823277 in Healthy Male Participants

Phase 1
Completed
Conditions
Healthy
Interventions
First Posted Date
2014-01-30
Last Posted Date
2014-01-30
Lead Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Target Recruit Count
6
Registration Number
NCT02049697

A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of JNJ-39393406 in Healthy Participants

Phase 1
Completed
Conditions
Healthy
Interventions
Other: Placebo
First Posted Date
2013-12-30
Last Posted Date
2014-01-24
Lead Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Target Recruit Count
88
Registration Number
NCT02023255

A Study of Solid Formulations of JNJ-39393406 in Healthy Male Participants

Phase 1
Completed
Conditions
Healthy
Interventions
Drug: JNJ 39393406 30 mg solid X
Drug: JNJ 39393406 30 mg solid Y
Drug: JNJ 39393406 120 mg solid X
Drug: JNJ 39393406 120 mg solid Y
Drug: JNJ 39393406 30 mg solution
First Posted Date
2013-11-18
Last Posted Date
2013-11-18
Lead Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Target Recruit Count
20
Registration Number
NCT01986491

A Study to Evaluate Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of JNJ-404118413 in Healthy Male Patients

Phase 1
Completed
Conditions
Healthy
Interventions
First Posted Date
2013-09-26
Last Posted Date
2013-09-26
Lead Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Target Recruit Count
18
Registration Number
NCT01951053

A Study to Evaluate Absorption, Metabolism, and Excretion of 14C-JNJ26489112 in Healthy Male Participants

Phase 1
Completed
Conditions
Healthy Participants
Interventions
Drug: 14C-JNJ26489112
First Posted Date
2013-09-24
Last Posted Date
2013-10-07
Lead Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Target Recruit Count
10
Registration Number
NCT01949610
Β© Copyright 2025. All Rights Reserved by MedPath